Surrozen, Inc./DE - *W EXP 08/01/203 (SRZNW)

CUSIP: 86889P117

Q2 2023 13F Holders as of 30 Jun 2023

Share change
-18,630
SEC-reported price per share
$0.06
Number of holders
16
Value change
-$1,071
Number of sells
2

Security key

86889P117

Report period

Q2 2023

Institutions

16

Top holders

10

Ownership snapshot

Top reported holders of SRZNW - Surrozen, Inc./DE - *W EXP 08/01/203 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Column Group LLC
Disclosed value leader
Column Group LLC
Comparable rows
0/15
Latest evidence
31 Mar 2023
13F 3/4/5 Highest disclosed value: $5,567,374 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Column Group LLC has the largest disclosed position value at $5.57M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Column Group LLC's linked filing trail.
Disclosed position value Top 5
Column Group LLC $5.57M
BML Capital Management, LLC $899.4K
Benny Soffer $716.3K
Kevin Harold Livingston $716.3K
Life Sciences Consonance $716.3K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Column Group LLC
13F
Company
13F
—
denominator unverified
$5,567,374
9,248,129 shares
— 31 Mar 2023
BML Capital Management, LLC
13F
Company
13F
—
denominator unverified
$899,410
1,494,037 shares
— 31 Mar 2023
Benny Soffer
3/4/5
FORMER DIRECTOR
—
mixed-class rows
$716,300
2,029,667 shares
mixed-class rows
— 11 Aug 2021
Kevin Harold Livingston
3/4/5
Former Chief Financial Officer
—
mixed-class rows
$716,300
2,029,667 shares
mixed-class rows
— 11 Aug 2021
Life Sciences Consonance
3/4/5
Former 10% Holder
—
mixed-class rows
$716,300
2,029,667 shares
mixed-class rows
— 11 Aug 2021
HARVARD MANAGEMENT CO INC
13F
Company
13F
—
denominator unverified
$497,765
826,852 shares
— 31 Mar 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
16
Shares
3,684,936
Rows available
16
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders
14
Q2 2023 holders
16
Holder diff
2
Investor Q1 2023 Shares Q2 2023 Shares Share Diff Share Chg % Q1 2023 value Q2 2023 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .